Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 7 studies | 35% ± 22% | |
glutamatergic neuron | 6 studies | 41% ± 23% | |
interneuron | 5 studies | 36% ± 21% | |
neuron | 3 studies | 20% ± 3% | |
epithelial cell | 3 studies | 27% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1548.56 | 652 / 653 | 96% | 5.05 | 579 / 605 |
pancreas | 98% | 977.88 | 321 / 328 | 97% | 4.33 | 173 / 178 |
lung | 86% | 840.31 | 498 / 578 | 99% | 6.83 | 1140 / 1155 |
prostate | 83% | 734.99 | 203 / 245 | 97% | 3.29 | 485 / 502 |
stomach | 76% | 742.29 | 272 / 359 | 98% | 4.38 | 279 / 286 |
adrenal gland | 83% | 482.90 | 214 / 258 | 88% | 4.08 | 203 / 230 |
brain | 93% | 3696.93 | 2452 / 2642 | 73% | 3.28 | 518 / 705 |
esophagus | 63% | 1605.39 | 904 / 1445 | 99% | 10.07 | 182 / 183 |
kidney | 97% | 839.33 | 86 / 89 | 62% | 1.79 | 557 / 901 |
breast | 49% | 363.36 | 223 / 459 | 98% | 5.51 | 1096 / 1118 |
ovary | 50% | 250.15 | 90 / 180 | 94% | 3.89 | 404 / 430 |
liver | 81% | 551.77 | 182 / 226 | 63% | 1.46 | 255 / 406 |
intestine | 45% | 424.89 | 431 / 966 | 99% | 4.51 | 520 / 527 |
skin | 71% | 1198.25 | 1292 / 1809 | 65% | 1.73 | 306 / 472 |
bladder | 29% | 161.00 | 6 / 21 | 93% | 3.98 | 471 / 504 |
uterus | 13% | 104.75 | 22 / 170 | 95% | 5.73 | 434 / 459 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.39 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 93% | 2.56 | 27 / 29 |
spleen | 92% | 616.05 | 222 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 1.51 | 61 / 80 |
muscle | 73% | 488.75 | 584 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 27% | 403.00 | 247 / 929 | 0% | 0 | 0 / 0 |
heart | 21% | 97.92 | 180 / 861 | 0% | 0 | 0 / 0 |
adipose | 7% | 32.40 | 82 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 3.25 | 7 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0000165 | Biological process | MAPK cascade |
GO_0005575 | Cellular component | cellular_component |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0004706 | Molecular function | JUN kinase kinase kinase activity |
GO_0004708 | Molecular function | MAP kinase kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | MAP3K9 |
Protein name | Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) Mitogen-activated protein kinase kinase kinase 9 Mitogen-activated protein kinase kinase kinase (EC 2.7.11.25) |
Synonyms | MLK1 PRKE1 |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Also plays a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. . |
Accessions | ENST00000554146.1 G3V4P9 G3V347 J3KPI6 ENST00000381250.8 ENST00000555993.6 [P80192-4] ENST00000553414.5 P80192 ENST00000554752.7 [P80192-1] |